3 not yet recruiting, 1 enrolling by invitation, 1 terminated. 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Severe Community-acquired Pneumonia (sCAP): new trials by email Literature Review of Severe Community-acquired Pneumonia (sCAP) trials Research Report on Severe Community-acquired Pneumonia (sCAP)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Epidemiology and Current Practices in Severe Community-Acquired Pneumonia Severe Community-acquired Pneumonia (sCAP) | Not yet recruiting | Universidad de la Sabana | 2588 | 2026-02-01 | 2026-01-15 | |
| Randomized Adaptive Platform Trial of Pathogen-Directed Anti-inflammatory Therapy in Severe Community-Acquired Pneumonia(Core Protocal) Low dose steroids, Moderate dose steroids, Saline (0.9% NaCl) - Severe Community-acquired Pneumonia (sCAP) | Phase 2 / Phase 3 | Not yet recruiting | Qingyuan Zhan | 1500 | 2025-09-08 | 2025-09-03 |
| Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea Piperacillin/Tazobactam, Piperacillin/tazobactam + Levofloxacin - Severe Community-acquired Pneumonia (sCAP) | Not applicable | Not yet recruiting | CHOSEOK YOON | 100 | 2025-06-15 | 2025-05-18 |
| ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly Patients Acquired Pneumonia in Elderly Patients Severe Community-Acquired Pneumonia (sCAP), Elderly Infection | Enrolling by invitation | Joan Sabater-Riera | 500 | 2025-05-01 | 2026-05-15 | |
| Molecular Biomarkers for Sepsis compare data patterns by data-driven algorithms to determine sepsis, compare data patterns by data-driven algorithms to predict sepsis-related mortality - Sepsis, Severe Community-acquired Pneumonia (sCAP) | Terminated | University Hospital, Basel, Switzerland | 3 | 2022-02-16 | 2024-05-09 |
Community-Acquired Pneumonia (5) · Bacterial Infections (1) · Community-Acquired Infections (1) · Pneumonia (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Sepsis (1)
Infections (5) · Community-Acquired Infections (4) · Pneumonia (4) · Respiratory Tract Diseases (4) · Respiratory Tract Infections (4) · Bacterial Infections and Mycoses (1) · Inflammation (1) · Lung Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Systemic Inflammatory Response Syndrome (1)
Levofloxacin (1) · Piperacillin (1) · Piperacillin, Tazobactam Drug Combination (1) · Sodium Chloride (1) · Steroids (1) · Tazobactam (1)
CHOSEOK YOON (1) · Joan Sabater-Riera (1) · Qingyuan Zhan (1) · Universidad de la Sabana (1) · University Hospital, Basel, Switzerland (1)
Colombia (1) · Croatia (1) · France (1) · Greece (1) · Italy (1) · Portugal (1) · South Korea (1) · Spain (1) · Switzerland (1)
Adrian Egli, PD Dr. (1) · Ignacio-Martin Loeches, MD, PhD, FJFICMI (1) · Jordi Rello, phD, MD (1) · Luis Felipe Reyes, MD, MSc, PhD (1)